Immune checkpoint inhibitors: new strategies to checkmate cancer

MLA

Alasdair R. Fraser, et al. “Immune Checkpoint Inhibitors: New Strategies to Checkmate Cancer.” Clinical and Experimental Immunology, vol. 191, Dec. 2017, pp. 133–48. EBSCOhost, https://doi.org/10.1111/cei.13081.

APA

Alasdair R. Fraser, Ruairi A. M. Wilson, Robert J. B. Nibbs, & Thomas J. Evans. (2017). Immune checkpoint inhibitors: new strategies to checkmate cancer. Clinical and Experimental Immunology, 191, 133–148. https://doi.org/10.1111/cei.13081

Chicago

Alasdair R. Fraser, Ruairi A. M. Wilson, Robert J. B. Nibbs, and Thomas J. Evans. 2017. “Immune Checkpoint Inhibitors: New Strategies to Checkmate Cancer.” Clinical and Experimental Immunology 191 (December): 133–48. doi:10.1111/cei.13081.